"More than 85 percent of patients in the four-drug treatment arms of ZENITH had undetectable hepatitis C virus at week 4 and, regardless of treatment duration, 90 percent of them cleared the hepatitis C virus," saidRobert Kauffman, M.D., Ph.D., Senior Vice President and Chief Medical Off...
Virahep-C Study Group. J Hepatol 2008; 49: 184–191. Genes and Immunity IL28B-associated SVR in Taiwanese chronic HCV infection J-Y Chen et al 45 Chen L, Sun J, Meng L, Heathcote J, Edwards AM, McGilvray ID. ISG15, a ubiquitin-like interferon-stimulated gene, pro- motes ...